ArticleBMC medical imaging2025
Colorectal cancer unmasked: A synergistic AI framework for Hyper-granular image dissection, precision segmentation, and automated diagnosis.
Article in BMC medical imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- An Attention-Enhanced ViT-HLNN Hybrid Ensemble Framework for Multi-Class Gastrointestinal Disease Classification.Scientific reports · 2026Article
- A Deep Learning Model Integrating Ultrasound Images and Multidimensional Clinical Information for Differentiating Benign and Malignant Non-Mass Lesions.Diagnostics (Basel, Switzerland) · 2026Article
- Multimodal foundation models in colorectal cancer: from prediction to trustworthy clinical insight.Briefings in bioinformatics · 2026Review
- MAP-SCTNet: multi-scale pyramid and frequency-enhanced network for colorectal cancer histopathological image segmentation.Frontiers in medicine · 2026Article
- Analyzing histopathological images using fused CNN features based on the geometric active contour method for early diagnosis of lung and colon cancer.Discover oncology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Colorectal cancer (CRC) is the second most common cause of cancer-related mortality worldwide, underscoring the necessity for computer-aided diagnosis (CADx) systems that are interpretable, accurate, and robust. This study presents a practical CADx system that combines Vision Transformers (ViTs) and DeepLabV3 + to accurately identify and segment colorectal lesions in colonoscopy images.The system addresses class balance and real-world complexity with PCA-based dimensionality reduction, data augmentation, and strategic preprocessing using recently curated CKHK-22 dataset comprising more than 14,000 annotated images of CVC-ClinicDB, Kvasir-2, and Hyper-Kvasir. ViT, ResNet-50, DenseNet-201, and VGG-16 were used to quantify classification performance. ViT achieved best-in-class accuracy (97%), F1-score (0.95), and AUC (92%) in test data. The DeepLabV3 + achieved segmentation state-of-the-art for tasks of localisation with 0.88 Dice Coefficient and 0.71 Intersection over Union (IoU), ensuring sharp delineation of areas that are malignant. The CADx system accommodates real-time inference and served through Google Cloud for information that accommodates scalable clinical implementation. The image-level segmentation effectiveness is evidenced by comparison with visual overlay and expert-manually deliminated masks, and its precision is illustrated by computation of precision, recall, F1-score, and AUC. The hybrid strategy not only outperforms traditional CNN strategies but also overcomes important clinical needs such as detection early, balance of highly disparate classes, and clear explanation. The proposed ViT-DeepLabV3 + system establishes a basis for advanced AI support to colorectal diagnosis by utilizing self-attention strategies and learning with different scales of context. The system offers a high-capacity, reproducible computerised colorectal cancer screening and monitoring solution and can be best deployed where resources are scarce, and it can be highly desirable for clinical deployment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.